InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001743548-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-03-04 2026-03-02+ ELV Norwood Felicia F EVP, Chief Health Benefits Ofr F - Tax $291.47 -1,917 30.5K -6% -$558.8K
DM 2026-03-04 2026-03-02 ELV Norwood Felicia F EVP, Chief Health Benefits Ofr A - Grant $0.00 +8,816 36.5K +32% $0
D 2026-03-04 2026-03-02 ELV Norwood Felicia F EVP, Chief Health Benefits Ofr A - Grant $0.00 +23.5K 23.5K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-03 F D 496 $284.03 38,838 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
2 Common Common Stock 2026-03-02 A A 2,865 $0.00 39,334 D — — (F3) Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
3 Common Common Stock 2026-03-02 A A 5,951 $0.00 36,469 D — — (F2) Represents restricted share units. Restrictions lapse as follows: 1,983 shares on 3/2/2027, and 1,984 shares each on 3/2/2028 and 3/2/2029.
4 Common Common Stock 2026-03-02 F D 1,421 $294.07 30,518 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
5 Derivative Employee Stock Option (Right to Buy) 2026-03-02 A A 23,512 $0.00 23,512 D $294.07 · — to 2036-03-02 23,512 Common Stock (F4) The option represents a right to purchase a total of 23,512 shares, and is exercisable in two installments of 7,837 shares each and one installment of 7,838 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.